These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1346562)

  • 21. The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy.
    Biernacki W; Prince K; Whyte K; MacNee W; Flenley DC
    Am Rev Respir Dis; 1989 Feb; 139(2):492-7. PubMed ID: 2563321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of tremor and efficacy of oral procaterol in adult patients with asthma.
    Tinkelman DG; DeJong R; Lutz C; Spangler DL
    J Allergy Clin Immunol; 1990 Apr; 85(4):719-28. PubMed ID: 1969869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.
    Richards DM; Brogden RN
    Drugs; 1985 Jul; 30(1):6-21. PubMed ID: 2863125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term oral bronchodilator therapy of asthma with pirbuterol.
    Burki NK; Diamond L
    Clin Pharmacol Ther; 1978 Jul; 24(1):84-9. PubMed ID: 657723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of skeletal muscle tremor due to bronchodilator agents.
    Thiringer G; Svedmyr N
    Scand J Respir Dis; 1975 Aug; 56(2):93-102. PubMed ID: 1166293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and cardiopulmonary effects in dogs of sublingual pirbuterol, a new bronchodilator.
    Constantine JW; McIlhenny HM; Moore PF
    J Pharmacol Exp Ther; 1979 Mar; 208(3):371-6. PubMed ID: 430357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.
    Weber RW; Nelson HS
    Pharmacotherapy; 1984; 4(1):1-10. PubMed ID: 6142449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tremor and β(2)-adrenergic agents: is it a real clinical problem?
    Cazzola M; Matera MG
    Pulm Pharmacol Ther; 2012 Feb; 25(1):4-10. PubMed ID: 22209959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aerosol pirbuterol: bronchodilator activity and side effects in ponies with recurrent airway obstruction (heaves).
    Derksen FJ; Robinson NE; Berney CE
    Equine Vet J; 1992 Mar; 24(2):107-12. PubMed ID: 1582387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
    Dawson JR; Canepa-Anson R; Kuan P; Whitaker NH; Carnie J; Warnes C; Reuben SR; Poole-Wilson PA; Sutton GC
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1423-6. PubMed ID: 6112039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tremor and the anti-obesity drug BRL 26830A.
    Connacher AA; Lakie M; Powers N; Elton RA; Walsh EG; Jung RT
    Br J Clin Pharmacol; 1990 Oct; 30(4):613-5. PubMed ID: 1981320
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose and dose-response studies with oral pirbuterol, a new beta agonist in chronic heart failure.
    Canepa-Anson R; Dawson JR; Kuan P; Warnes CA; Poole-Wilson PA; Reuben SR; Sutton GC
    Am Heart J; 1981 Sep; 102(3 Pt 2):578-83. PubMed ID: 6115575
    [No Abstract]   [Full Text] [Related]  

  • 33. Skeletal muscle tremor and the influence of adrenergic drugs.
    Ahrens RC
    J Asthma; 1990; 27(1):11-20. PubMed ID: 1968452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adverse reactions to beta 2-agonist bronchodilators.
    Lulich KM; Goldie RG; Ryan G; Paterson JW
    Med Toxicol; 1986; 1(4):286-99. PubMed ID: 2878344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Level of lactates and examinations of tremor under Clenbuterol (NAB 365)].
    Renovanz HD; Nonhoff R
    Wien Med Wochenschr Suppl; 1975; 23():14-9. PubMed ID: 1094750
    [No Abstract]   [Full Text] [Related]  

  • 36. Tremor side effects of salbutamol, quantified by a laser pointer technique.
    Nizet TA; Broeders ME; Folgering HT
    Respir Med; 2004 Sep; 98(9):844-50. PubMed ID: 15338796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicenter study of bitolterol and isoproterenol nebulizer solutions in nonsteroid-using patients.
    Pinnas JL; Bernstein IL; Bronsky EE; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Nathan RA; Repsher LH; Bhatt BD
    J Allergy Clin Immunol; 1987 May; 79(5):768-75. PubMed ID: 3571768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic advantages of the newer bronchodilator compounds.
    Tashkin DP
    Chest; 1977 Feb; 71(2):125-6. PubMed ID: 188599
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of increasing dosage of an inhaled beta-2 specific agonist on pulmonary function, tremor, and cardiovascular indices.
    Tinkelman DG; Lutz C
    Ann Allergy; 1992 Jan; 68(1):23-6. PubMed ID: 1346562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maximum bronchodilator effect of pirbuterol and procaterol administered as sprays with and without an aerochamber.
    Solé D; Villalba SR; Sestelo MR; Scalabrin DM; Soares FJ; Naspitz CK
    Rev Paul Med; 1993; 111(3):397-402. PubMed ID: 8108632
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.